cas 1152850-20-8|| where to buy 5-(3-chloro-4-fluorophenyl)-5-methylimidazolidine-2,4-dione

Nom du produit:5-(3-chloro-4-fluorophenyl)-5-methylimidazolidine-2,4-dione

IUPAC Name:5-(3-chloro-4-fluorophenyl)-5-methylimidazolidine-2,4-dione

: CAS：1152850-20-8; Formule moléculaire：C10H8ClFN2O2; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM473504-50mg	in stock	ȤȅȤ
CM473504-100mg	in stock	ŸȤǠ
CM473504-250mg	in stock	ƐǠǠ
CM473504-500mg	in stock	œœȤȤ
CM473504-1g	in stock	œŸȖƐ
CM473504-5g	in stock	ŸǆŸŸ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1152850-20-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1152850-20-8; Formule moléculaire:C10H8ClFN2O2; Point de fusion:-; Code SMILES:CC1(NC(=O)NC1=O)C1=CC(Cl)=C(F)C=C1; Densité:

: Numéro de catalogue:CM473504; Poids moléculaire:242.63; Point d'ébullition:; N° Mdl:MFCD11156248; Stockage:

: Imidazolidines; Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.; imidazolidine supplier; As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.